BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
BAY 61-3606 (Syk inhibitor IV) is an active, ATP-competitive reversible selective Syk inhibitor. It acts on breast cancer cells and promotes TRAIL-induced apoptosis by down-regulating Mcl-1.
Biochem/physiol Actions Bay-X-1005 is a potent inhibitor of 5-lipoxygenase activating protein (FLAP). Bay-X-1005 inhibits A23187-induced LTB4 production in human leucocytes with an IC 50 value of 220 nM, and blocks IgE mediated airway
Biochem/physiol Actions Bay-X-1005 is a potent inhibitor of 5-lipoxygenase activating protein (FLAP). Bay-X-1005 inhibits A23187-induced LTB4 production in human leucocytes with an IC 50 value of 220 nM, and blocks IgE mediated airway
Biochem/physiol Actions Bay-X-1005 is a potent inhibitor of 5-lipoxygenase activating protein (FLAP). Bay-X-1005 inhibits A23187-induced LTB4 production in human leucocytes with an IC 50 value of 220 nM, and blocks IgE mediated airway
Biochem/physiol Actions Bay-X-1005 is a potent inhibitor of 5-lipoxygenase activating protein (FLAP). Bay-X-1005 inhibits A23187-induced LTB4 production in human leucocytes with an IC 50 value of 220 nM, and blocks IgE mediated airway
General description Raka-Ray Agar was formulated by Saha, Sondag and Middlekauff to monitor the brewing process and analyze it for a wide range of bacteria. The media is found to be superior to several other media for the cultivation of
General description Raka-Ray Agar was formulated by Saha, Sondag and Middlekauff to monitor the brewing process and analyze it for a wide range of bacteria. The media is found to be superior to several other media for the cultivation of